US Stock MarketDetailed Quotes

TFFP TFF Pharmaceuticals

Watchlist
  • 0.3050
  • +0.0010+0.33%
Close Nov 27 16:00 ET
  • 0.3041
  • -0.0009-0.30%
Post 20:01 ET
1.36MMarket Cap-55P/E (TTM)

TFF Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-44.02%106.05K
95.06%650.22K
295.25%203.27K
0
-574.23K
189.45K
333.35K
51.43K
0
0
Operating revenue
-44.02%106.05K
95.06%650.22K
295.25%203.27K
--0
---574.23K
--189.45K
--333.35K
--51.43K
--0
--0
Cost of revenue
Gross profit
Operating expense
-20.00%3.69M
-13.82%4.61M
-16.02%5.99M
-31.14%21.89M
-35.04%4.79M
-36.68%4.61M
-38.85%5.35M
-14.85%7.14M
0.03%31.8M
-26.90%7.38M
Selling and administrative expenses
-10.19%1.96M
-23.79%1.92M
-18.32%2.32M
-23.41%10.57M
-14.93%3.03M
-34.87%2.18M
-31.38%2.52M
-11.62%2.84M
30.47%13.8M
11.59%3.56M
-General and administrative expense
-10.19%1.96M
-23.79%1.92M
-18.32%2.32M
-23.41%10.57M
-14.93%3.03M
-34.87%2.18M
-31.38%2.52M
-11.62%2.84M
30.47%13.8M
11.59%3.56M
Research and development costs
-26.56%1.82M
-4.91%2.69M
-14.50%3.67M
-34.79%12.06M
-40.61%2.46M
-38.44%2.48M
-44.56%2.83M
-17.94%4.3M
-13.17%18.5M
-40.23%4.14M
Other operating expenses
-92.74%-87.34K
----
----
-48.02%-733.87K
-120.14%-688.56K
48.26%-45.31K
----
----
-462.39%-495.81K
-2,507.37%-312.78K
Operating profit
18.97%-3.58M
21.05%-3.96M
18.28%-5.79M
31.14%-21.89M
27.26%-5.37M
39.28%-4.42M
42.66%-5.02M
15.47%-7.09M
-0.03%-31.8M
26.90%-7.38M
Net non-operating interest income expense
-58.23%37.1K
21.32%43.82K
58.92%55.75K
895.91%266.19K
1,307.46%106.18K
1,351.38%88.81K
514.29%36.12K
388.23%35.08K
-47.83%26.73K
-21.52%7.54K
Non-operating interest income
-58.23%37.1K
21.32%43.82K
58.92%55.75K
895.91%266.19K
1,307.46%106.18K
1,351.38%88.81K
514.29%36.12K
388.23%35.08K
-47.83%26.73K
-21.52%7.54K
Other net income (expense)
-1,397.95%-560.47K
385.24K
500.11K
-77.45K
-37.42K
Gain on sale of security
----
-1,397.95%-560.47K
----
--385.24K
--500.11K
---77.45K
---37.42K
----
----
----
Income before tax
19.60%-3.54M
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
Income tax
Net income
19.60%-3.54M
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
Net income continuous Operations
19.60%-3.54M
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
Minority interest income
Net income attributable to the parent company
19.60%-3.54M
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.60%-3.54M
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
Basic earnings per share
65.09%-0.81
64.84%-1.22
50.72%-2.4
55.27%-11.85
37.75%-1.55
68.00%-2.32
59.18%-3.47
40.97%-4.87
15.23%-26.49
75.10%-2.49
Diluted earnings per share
65.09%-0.81
64.84%-1.22
50.72%-2.4
55.27%-11.85
37.75%-1.55
68.00%-2.32
59.18%-3.47
40.97%-4.87
15.23%-26.49
75.10%-2.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -44.02%106.05K95.06%650.22K295.25%203.27K0-574.23K189.45K333.35K51.43K00
Operating revenue -44.02%106.05K95.06%650.22K295.25%203.27K--0---574.23K--189.45K--333.35K--51.43K--0--0
Cost of revenue
Gross profit
Operating expense -20.00%3.69M-13.82%4.61M-16.02%5.99M-31.14%21.89M-35.04%4.79M-36.68%4.61M-38.85%5.35M-14.85%7.14M0.03%31.8M-26.90%7.38M
Selling and administrative expenses -10.19%1.96M-23.79%1.92M-18.32%2.32M-23.41%10.57M-14.93%3.03M-34.87%2.18M-31.38%2.52M-11.62%2.84M30.47%13.8M11.59%3.56M
-General and administrative expense -10.19%1.96M-23.79%1.92M-18.32%2.32M-23.41%10.57M-14.93%3.03M-34.87%2.18M-31.38%2.52M-11.62%2.84M30.47%13.8M11.59%3.56M
Research and development costs -26.56%1.82M-4.91%2.69M-14.50%3.67M-34.79%12.06M-40.61%2.46M-38.44%2.48M-44.56%2.83M-17.94%4.3M-13.17%18.5M-40.23%4.14M
Other operating expenses -92.74%-87.34K---------48.02%-733.87K-120.14%-688.56K48.26%-45.31K---------462.39%-495.81K-2,507.37%-312.78K
Operating profit 18.97%-3.58M21.05%-3.96M18.28%-5.79M31.14%-21.89M27.26%-5.37M39.28%-4.42M42.66%-5.02M15.47%-7.09M-0.03%-31.8M26.90%-7.38M
Net non-operating interest income expense -58.23%37.1K21.32%43.82K58.92%55.75K895.91%266.19K1,307.46%106.18K1,351.38%88.81K514.29%36.12K388.23%35.08K-47.83%26.73K-21.52%7.54K
Non-operating interest income -58.23%37.1K21.32%43.82K58.92%55.75K895.91%266.19K1,307.46%106.18K1,351.38%88.81K514.29%36.12K388.23%35.08K-47.83%26.73K-21.52%7.54K
Other net income (expense) -1,397.95%-560.47K385.24K500.11K-77.45K-37.42K
Gain on sale of security -----1,397.95%-560.47K------385.24K--500.11K---77.45K---37.42K------------
Income before tax 19.60%-3.54M10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M
Income tax
Net income 19.60%-3.54M10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M
Net income continuous Operations 19.60%-3.54M10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M
Minority interest income
Net income attributable to the parent company 19.60%-3.54M10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.60%-3.54M10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M
Basic earnings per share 65.09%-0.8164.84%-1.2250.72%-2.455.27%-11.8537.75%-1.5568.00%-2.3259.18%-3.4740.97%-4.8715.23%-26.4975.10%-2.49
Diluted earnings per share 65.09%-0.8164.84%-1.2250.72%-2.455.27%-11.8537.75%-1.5568.00%-2.3259.18%-3.4740.97%-4.8715.23%-26.4975.10%-2.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data